PASG Q2 2021 Earnings — Passage Bio, Inc. Revenue & Financial Results | Market Cap Arena

PASGPassage Bio, Inc.

$28M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$49M

Net Income

-$48M

EPS (Diluted)

$-18.00

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$30M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$440M

Total Liabilities

$37M

Stockholders' Equity

$402M

Cash & Equivalents

$215M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$49M	-$27M	-77.8%
Net Income	-$48M	-$27M	-78.3%